 Kazia Therapeutics Ltd ASX:KZA, NASDAQ:KZIA has appointed John Friend MD, the former chief medical officer CMO at Cellectar Biosciences NASDAQ:CLRB, Inc as its new CMO. Dr Friend will be responsible for overseeing the development and commercialization of Kazias pipeline drug candidates, and collaborate with clinicians and scientists to advance the companys research programs. 